903
Views
6
CrossRef citations to date
0
Altmetric
Original Articles

Synthesis and characterization of smart N-isopropylacrylamide-based magnetic nanocomposites containing doxorubicin anti-cancer drug

, , &
Pages 560-567 | Received 26 Nov 2015, Accepted 29 Feb 2016, Published online: 19 May 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Fatima Pashaei-Asl, Roghiyeh Pashaei-Asl, Khodadad Khodadadi, Abolfazl Akbarzadeh, Esmaeil Ebrahimie & Maryam Pashaiasl. (2018) Enhancement of anticancer activity by silibinin and paclitaxel combination on the ovarian cancer. Artificial Cells, Nanomedicine, and Biotechnology 46:7, pages 1483-1487.
Read now

Articles from other publishers (5)

Yonglei Lyu, Xiaoxia Wu, Anastassios C. Papageorgiou, Jinghui Yang, Xin Wang, Dawei Qi & Jianwei Li. (2022) Dynamic covalent macrocycles co-delivering genes and drugs against drug-resistant cancer. Cell Reports Physical Science 3:11, pages 101150.
Crossref
Gülcan Geyik & Nuran Işıklan. (2021) Design and fabrication of hybrid triple-responsive κ-carrageenan-based nanospheres for controlled drug delivery. International Journal of Biological Macromolecules 192, pages 701-715.
Crossref
Peng Zhao, Jiajin Zhang, Wei Zhang, Dong Zhao, Yi Ma, Changjun Hou, Laichun Lu & Danqun Huo. (2021) Fabrication of a novel hydrogel-based microfluidic chip and its application in pathogen analysis. Analytical Methods 13:43, pages 5240-5246.
Crossref
Zhen Li, Jun Huang & Jun Wu. (2021) pH-Sensitive nanogels for drug delivery in cancer therapy. Biomaterials Science 9:3, pages 574-589.
Crossref
Fatemeh Abedi, Soodabeh Davaran, Malak Hekmati, Abolfazl Akbarzadeh, Behzad Baradaran & Sevil Vaghefi Moghaddam. (2021) An improved method in fabrication of smart dual-responsive nanogels for controlled release of doxorubicin and curcumin in HT-29 colon cancer cells. Journal of Nanobiotechnology 19:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.